Physicians may be rotating three-dimensional medical images ontheir desktop personal computers within the next five years. SiliconGraphics plans to be a factor in the mass 3-D market when it emerges,said John C. Metcalfe, vice president of marketing for
Physicians may be rotating three-dimensional medical images ontheir desktop personal computers within the next five years. SiliconGraphics plans to be a factor in the mass 3-D market when it emerges,said John C. Metcalfe, vice president of marketing for SiliconGraphic's Entry Systems division.
The Mountain View, CA, firm is a leading supplier of 3-D workstationtechnology for medical and other technical applications. Severalsignificant steps were taken this month to help spread its graphicstechnology:
"We were the first workstation company to use the MIPSRISC processor. The ACE standard virtually describes a low-endSilicon Graphics workstation. It endorses our view of what a workstationshould be," Metcalfe told SCAN.
Under the ACE initiative, when a software developer writesan application for one of the computer suppliers in the consortium,the program will run on any of the others, he said. ACE will bein competition with proprietary RISC systems offered by Sun Microsystemsand IBM.
All three agreements should ensure that Silicon Graphics hardwareand processing technology is available to a wide audience andis compatible with generally available computer applications,Metcalfe said.
"The PC of 1995 will handle 3-D images in the same waycurrent PCs handle color. That is going to have a fundamentaleffect on how people in the medical industry will use (computer)products," he said.
While no specific product plans were included in the Compaqagreement, the two firms will share technology in their productdevelopment programs. Compaq will also purchase 13% of SiliconGraphics' equity for $135 million and provide the graphics firmwith $50 million for R&D.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.